Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 May 15;13(5):546-557.
doi: 10.1016/j.chom.2013.04.004.

Memory CD8⁺ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection

Affiliations

Memory CD8⁺ T cells can outsource IFN-γ production but not cytolytic killing for antiviral protection

Sanda Remakus et al. Cell Host Microbe. .

Abstract

Immunization with vaccinia virus (VACV), the virus comprising the smallpox vaccine, induces memory CD8(+) T cells that protect from subsequent infections with smallpox in humans or the related ectromelia virus (ECTV) in mice. Memory CD8(+) T cells largely mediate these effects by expanding into secondary effectors that secrete the antiviral cytokine interferon-γ (IFN-γ) and induce cytolysis via releasing factors such as perforin, which permeabilizes target cells. We show that protection from ECTV infection after VACV immunization depends on the initial memory cell frequency and ability of expanded secondary effectors to kill infected targets in a perforin-dependent manner. Although IFN-γ is essential for antiviral protection, it can be produced by either secondary effectors or concomitant primary effector CD8(+) T cells recruited to the response. Thus, during lethal virus challenge, memory CD8(+) T cells are required for cytolytic killing of infected cells, but primary effectors can play important roles by producing IFN-γ.

PubMed Disclaimer

Figures

Figure 1
Figure 1. M-WT but not M-IFN-γ−/− CD8+ T cells efficiently protect IFN-γ−/− mice from mousepox
A) IFN-γ−/− mice received 5×106 N-WT, M-WT or M-IFN-γ−/− CD8+ T cells and infected with ECTV. Survival was monitored. The experiment is representative of three, where n=5 for every group except M-IFN-γ−/− where n=6. B) The mice in A were weighed daily. C) IFN-γ−/− mice that received 5×106 N-WT, M-WT or M-IFN-γ−/− CD8+ T cells were infected with ECTV. Seven days p.i., mice were killed and virus titers determined in liver. Data corresponds to five mice per group ± SEM and is representative of two independent experiments. D) As in C but the virus titers were determined in spleen. Also see Figure S1 for liver pathology.
Figure 2
Figure 2. M-WT and M-IFN-γ−/− CD8+ T cells respond strongly in the liver and spleen of IFN-γ−/− mice
IFN-γ−/− mice received 5×106 N-WT, M-WT or M-IFN-γ−/− CD8+ T cells. One day later, the mice were infected with ECTV and at 7 dpi the mononuclear cells infiltrating the livers (A-F) and splenocytes (G-L) were incubated for 5 h with TSYKFESV or without peptide and the indicated parameters were determined. Data corresponds to an experiment with five mice per group ± SEM, with exception of N-WT that had 2 mice/group because three mice died at 7 dpi. Data are representative of two experiments. Data are represented as a mean ± SEM. Representative flow cytometry plots are shown in Figure S2.
Figure 3
Figure 3. Memory CD8+ T cells deficient in IFN-γ but not in Prf protect susceptible mice from lethal mousepox
CD8+ cells were magnetically purified from pooled LNs and spleens from donor naïve or VACV immune B6, IFN-γ−/− or Prf−/− mice. 106, 2.5×106 or 5×106 CD8+ purified CD8+ T cells from each type of donor cell were transferred i.v. into groups of 5 B6.D2-D6 mice. One day later the mice were infected with ECTV and survival was monitored. A) The frequency of CD8+ T cells specific for the immunodominant determinant TSYKFESV was determined by staining with Kb- TSYKFESV dimers. B) Kaplan-Meier survival curve for mice transferred with ~65,000 Kb- TSYKFESV+ cells as determined from the results in A. C) Kaplan-Meier survival curve for mice transferred with ~130,000 Kb- TSYKFESV+ cells as determined from the results in A. All mice transferred with 106 M-WT or M-Prf−/− (~25,000 Kb-TSYKFESV+ cells) succumbed to the infection, all the mice transferred with 5×106 M-IFN-γ−/− (~270,000 Kb-TSYKFESV+ cells) survived and are not displayed graphically. D,E) Virus titers at 7 dpi in livers (D) and spleens (E) from B6.D2-D6-Thy1.1+ mice that received 5×106 N-WT CD8+ T cells, or enough M-WT, M-IFN-γ−/− or M-Prf−/− CD8+ T cells to contain ~75,000 Kb-TSYKFESV+ cells. Data are represented as a mean ± SEM and are representative of two independent experiments.
Figure 4
Figure 4. Endogenous Prf but not IFN-γ in memory CD8+ T cells is required for the early control of ECTV LH spread
A-B) Virus titers at 7 dpi in livers (A) and spleens (B) from B6.D2-D6 mice that received 5×106 N-WT CD8+ T cells, or enough MWT, M-IFN-γ−/− or M-Prf−/− CD8+ T cells to contain ~75,000 Kb-TSYKFESV+ cells. Data are representative of three independent experiments. C-J) N-WT, M-WT, M-IFN-γ−/− or M-Prf−/− CD8+ T cells were labeled with CFSE to identify divided donor cells. 5×106 N-WT CD8+ T cells or a number of M-WT, M-IFN-γ−/− or M-Prf−/− CD8+ T cells that contained ~75,000 Kb-TSYKFESV+ cells were transferred into B6.D2-D6-Thy1.1+ mice. One day later, the mice were infected with ECTV and at 4 dpi D-LN cells were counted and analyzed by flow cytometry. The indicated parameters were analyzed. Data are represented as a mean ± SEM and are representative of two similar experiments. Representative flow cytometry plots are shown in (E). Also see Figure S3 for Cidofovir treated mice and confocal microscopy, respectively.
Figure 5
Figure 5. Endogenous Prf but not IFN-γ in memory CD8+ T cells is required for the late control of ECTV in the liver and spleen
B6.D2-D6-Thy1.1+ mice received 5×106 N-WT CD8+ T cells, or enough M-WT, M-IFN-γ−/− or M-Prf−/− CD8+ T cells to contain ~75,000 Kb-TSYKFESV+ cells. One day later, the mice were infected with ECTV and at 7 dpi: A-I) Liver infiltrating mononuclear cells (J-R) and splenocytes were incubated for 5 h with TSYKFESV or without peptide and the indicated parameters were determined. Data correspond to five mice per group with exception of uninfected mice that had 4 mice/group and N-WT that had 3 mice/group because two mice died at 7 dpi. Data are represented as a mean ± SEM and are representative of two experiments using B6.D2-D6 Thy1.1+ recipients (shown) and a third experiment using B6.D2-D6 mice as recipients. See Figure S4 for representative flow cytometry plots and for higher ECTV doses and VACV and LCMV infection.
Figure 6
Figure 6. N-WT T cells can complement M-IFN-γ−/− CD8+ T cells to protect IFN-γ−/− mice from mousepox
IFN-γ−/− mice were transferred with 2.5×106 M-IFN-γ−/− CD8+ T cells and/or with 5×107 leukocytes (pooled splenocytes, LN cells and liver mononuclear cells) from naïve B6 mice that had been depleted or not of CD4+, CD8+, CD4+ and CD8+ T cells, or NK cells as indicated. One day after transfer, the mice were challenged with ECTV in the footpad. A) Survival. B) Weight loss. Data correspond to the mean of five mice per group ± SEM and is representative of two independent experiments. Also see Figure S5.

Similar articles

Cited by

References

    1. Badovinac VP, Messingham KA, Hamilton SE, Harty JT. Regulation of CD8+ T cells undergoing primary and secondary responses to infection in the same host. J Immunol. 2003;170:4933–4942. - PubMed
    1. Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. Journal of immunological methods. 2003;281:65–78. - PubMed
    1. Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, Abraham J, Lederman MM, Benito JM, Goepfert PA, Connors M, et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. Blood. 2006;107:4781–4789. - PMC - PubMed
    1. Billiau A, Matthys P. Interferon-gamma: a historical perspective. Cytokine & growth factor reviews. 2009;20:97–113. - PubMed
    1. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nature reviews. Immunology. 2001;1:41–49. - PubMed

Publication types

MeSH terms